CADUS PHARMACEUTICAL CORP (Form: 3, Received: 07/29/1996 00:00:00)

FORM 3

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a)
of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940

1. Name and Address of Reporting Person

Physica B.V.

(Last) (First) (Middle)

C.J. van Houtenlaan 36

(Street)

1381 CP Weesp The Netherlands

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)

07/17/96

3. IRS or Social Security Number of Reporting Person (Voluntary)

4. Issuer Name and Ticker or Trading Symbol

Cadus Pharmaceutical Corporation: KDUS

5. Relationship of Reporting Person to Issuer:

(Check all applicable)

      Director           X     10% Owner
-----                  -----

       Officer                 Other (Specify
-----                  -----          below)

-------------------------------------

6. If Amendment, Date of Original (Month/Day/Year)

- -----------------------------------------------------------------------------------------------------------------------------------
                                            TABLE 1 -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
- -----------------------------------------------------------------------------------------------------------------------------------
 1. Title of Security                         2. Amount of Securities         3. Ownership Form:   4. Nature of Indirect
    (Instr. 4)                                   Beneficially Owned              Direct (D) or              Beneficial
                                                 (Instr. 4)                      Indirect (I)               Ownership (Instr. 5)
                                                                                 (Instr. 5)
- -----------------------------------------  ----------------------------  -------------------------  -------------------------------
Common Stock, $.01 par value                      1,599,942 shares                     D            Not Applicable
- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------

- -----------------------------------------  ----------------------------  ------------------------   -------------------------------


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.                   (Over)
                                                                               (Print or Type Responses)             SEC 1473 (8/92)

FORM 3 (CONTINUED)               TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
                            (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security  2. Date            3. Title and Amount of         4. Conver-    5. Owner-   6. Nature of Indirect
   (Instr. 4)                       Exercisable and    Securities Underlying          sion or       ship        Beneficial Ownership
                                    Expiration Date    Derivative Security            Exercise      Form of     (Instr. 5)
                                    (Month/Day/        (Instr. 4)                     Price of      Deriv-
                                    Year)                                             Deri-         ative
                                                                                      vative        Security:

                                                                                      Security      Direct
                                 -------------------------------------------------                  (D) or
                                 Date      Expira-                       Amount or                  Indirect (I)
                                 Exercis-  tion             Title        Number                     (Instr. 5)
                                 able      Date                          of Shares
- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

- -------------------------------  --------  -----------  ---------------  -----------  ------------  -----------  -----------------

Explanation of Responses:

By: /s/ DR. JAN WILLEM FREDERIK VAN INGEN        July 27, 1996
   --------------------------------------         ------------
    Dr. Jan Willem Frederik van Ingen, Director       Date
    **Signature of Reporting Person

**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note. File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.

No data